Health
Researchers test novel gene regulation approach to treat brain diseases – News-Medical.Net
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation…
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer’s in laboratory studies. It leverages zinc finger proteins, which specifically bind to the DNA that codes for the protein Tau without altering it, thereby reducing Tau production in the brain and preventing nerve damage. The preclinical results, published in the journal Science Advances,…
-
General20 hours agoWondering about winter | The Spectator Australia
-
Noosa News19 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General18 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Business24 hours agoAre Domain Holdings shares undervalued?